According to the GuruFocus All-In-One Screener, the following health care stocks are popular among guru investors.
Thirty-six gurus are invested in Johnson & Johnson (JNJ). The diverse health care company has a market cap of $370.68 billion. Its revenue of $80.64 billion has increased 2.40% over a 10-year period.
The stock is trading with a price-book ratio of 5.89. As of Tuesday, the price of $138.17 is 6.84% below its 52-week high and 16.48% above its 52-week low. Over the last 10 years, it has returned a gain of 104%.
The company’s largest shareholder among the gurus is Ken Fisher (Trades, Portfolio) with 0.49% of outstanding shares, followed by Barrow, Hanley, Mewhinney & Strauss with 0.33% and Yacktman Asset Management (Trades, Portfolio) with 0.19%.
Twenty-five gurus have positions in Pfizer Inc. (PFE, Financial). The pharmaceutical company has a market cap of $258.34 billion. Its revenue of $53.24 billion has grown 1.80% over the past decade.
The stock is trading with a price-book ratio of 3.70. The current price of $44.07 is 0.87% below its 52-week high and 32.74% above its 52-week low. Over the past decade, it has returned a gain of 135%.
Fisher is the largest guru shareholder of the company with 0.67% of outstanding shares, followed by Barrow, Hanley, Mewhinney & Strauss with 0.67% and Pioneer Investments (Trades, Portfolio) with 0.27%.
Twenty gurus are invested in GlaxoSmithKline PLC (GSK, Financial). The company, which develops and manufactures respiratory and antiviral vaccines and health-related consumer products, has a $100.73 billion market cap. Its revenue of $40.50 billion has risen 1.93% over the last 10 years.
The stock is trading with a price-book ratio of 20.71. The current price of $40.17 is 5.17% below its 52-week high and 16.37% above its 52-week low. Over the past decade, it has returned a loss of 6%.
The company’s largest shareholder among the gurus is Dodge & Cox with 1.94% of outstanding shares, followed by Fisher with 0.56%, Jim Simons (Trades, Portfolio)' Renaissance Technologies with 0.38% and Hotchkis & Wiley with 0.34%.
Merck & Co. Inc. (MRK, Financial) is held by 26 gurus. The pharmaceutical company has a market cap of $188.67 billion. Its revenue of $41.26 billion has grown 2.50% per annum over the last 10 years.
The stock is trading with a price-book ratio of 5.82. The current price of $70.94 is 0.89% below its 52-week high and 34.28% above its 52-week low. Over the last 10 years, it has returned a 128% gain.
With 0.87% of outstanding shares, the Vanguard Health Care Fund (Trades, Portfolio) is the company's largest guru shareholder, followed by Fisher with 0.3%, Pioneer Investments with 0.25% and Richard Pzena (Trades, Portfolio) with 0.24%.
AbbVie Inc. (ABBV, Financial) is held by 22 gurus. The pharmaceutical company has a market cap of $143.22 billion.
The stock is trading with a price-earnings ratio of 23.41. The current price of $94.58 is 24.40% below its 52-week high and 11.63% above its 52-week low. Over the last 10 years, it has returned a gain of 170%.
The company’s largest guru shareholder is Simons with 0.16% of outstanding shares, followed by Fisher with 0.05%, Joel Greenblatt (Trades, Portfolio) with 0.03% and Jeremy Grantham (Trades, Portfolio) with 0.02%.
Disclosure: I do not own any stocks mentioned in this article.
Also check out:
